Infliximab-Responsive Severe Ulcerative Colitis With Pyoderma Gangrenosum After IL-6 and IGF-1 Blockade.
Interleukin-6 (IL-6) and insulin-like growth factor-1 (IGF-1) are involved in immune regulation and tissue repair, but their combined effects on gastrointestinal mucosa remain unclear. We report a case of new-onset ulcerative colitis with pyoderma gangrenosum after sequential IL-6 and IGF-1 receptor...
| Publicado en: | ACG Case Reports Journal Vol. 13; no. 6; pp. 1 - 5 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | case study pictorial Journal Article |
| Publicado: |
American College of Gastroenterology
Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |